Ke‐Neng Chen
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Cancer-related gene regulation
- Developmental Biology and Gene Regulation
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Genomics, phytochemicals, and oxidative stress
Papers in
- Surgery 13
- Esophageal Cancer Research and Treatment 12
- Esophageal and GI Pathology 2
-
- Cancer-related gene regulation 4
- Developmental Biology and Gene Regulation 4
- Wnt/β-catenin signaling in development and cancer 3
- Epigenetics and DNA Methylation 2
- Co-authors
- Luyan Shen (12 shared papers)Wanpu Yan (13 shared papers)Xiaozheng Kang (9 shared papers)Yao Lin (5 shared papers)Simin Li (1 shared paper)Qi Shi (4 shared papers)Bin Dong (4 shared papers)Xiaotian Shi (1 shared paper)
- Journals
- Annals of Surgical Oncology (3 papers)Thoracic Cancer (10 papers)Cancer Letters (1 paper)Clinical Cancer Research (1 paper)Medicine (1 paper)
- Partner nations
- ChinaEthiopiaUnited States
In The Last Decade
Ke‐Neng Chen
29 papers receiving 526 citations
Peers
Comparison fields: 5 of 57
- Cancer Research 128
- Molecular Biology 308
- Surgery 100
- Oncology 58
- Pulmonary and Respiratory Medicine 57
Countries citing papers authored by Ke‐Neng Chen
This map shows the geographic impact of Ke‐Neng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke‐Neng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke‐Neng Chen more than expected).
Fields of papers citing papers by Ke‐Neng Chen
This network shows the impact of papers produced by Ke‐Neng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke‐Neng Chen. The network helps show where Ke‐Neng Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Ke‐Neng Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 68 | |
| 2 | 2009 | 57 | |
| 3 | 2005 | 56 | |
| 4 | 2018 | 35 | |
| 5 | 2014 | 33 | |
| 6 | 2014 | 33 | |
| 7 | Genome-scale CRISPR activation screening identifies a role of ELAVL2-CDKN1A axis in paclitaxel resistance in esophageal squamous cell carcinoma. | 2019 | 25 |
| 8 | 2019 | 25 | |
| 9 | 2018 | 23 | |
| 10 | 2015 | 21 | |
| 11 | 2015 | 19 | |
| 12 | 2018 | 17 | |
| 13 | 2024 | 14 | |
| 14 | 2018 | 14 | |
| 15 | 2015 | 14 | |
| 16 | 2021 | 12 | |
| 17 | 2015 | 11 | |
| 18 | 2011 | 11 | |
| 19 | 2019 | 9 | |
| 20 | 2011 | 9 |
About Ke‐Neng Chen
Ke‐Neng Chen is a scholar working on Surgery, Molecular Biology, Pulmonary and Respiratory Medicine, Oncology and Genetics, having authored 30 papers that have together received 527 indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (12 papers), Cancer-related gene regulation (4 papers), Developmental Biology and Gene Regulation (4 papers), Wnt/β-catenin signaling in development and cancer (3 papers), Lung Cancer Treatments and Mutations (3 papers), Epigenetics and DNA Methylation (2 papers), Esophageal and GI Pathology (2 papers) and Gastric Cancer Management and Outcomes (2 papers). The work is most often cited by research in Cancer Research (128 citations), Molecular Biology (308 citations), Surgery (100 citations), Oncology (58 citations) and Pulmonary and Respiratory Medicine (57 citations). Ke‐Neng Chen has collaborated with scholars based in China, Ethiopia and United States. Frequent co-authors include Luyan Shen, Wanpu Yan, Xiaozheng Kang, Yao Lin, Simin Li, Qi Shi, Bin Dong, Xiaotian Shi, Guang‐wei Xu and Jiyou Li. Their work appears in journals such as Annals of Surgical Oncology, Thoracic Cancer, Cancer Letters, Clinical Cancer Research and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.